BioVie Inc. (BIVI) Social Stream



BioVie Inc. (BIVI): $3.12

0.24 (-7.14%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

Add BIVI to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#174 of 332

in industry

Featured Post From StockTwits About BIVI

$BIVI I spoke to Terren today. He’s extremely bullish on the company. Cuong Do , the former Chief Strategic Officer of Merck , and the CEO of BIVi believes this has the potential of the biggest drug in history. Factually the company will have 3 pivotal Phase 3 studies in effect next year. They dosed the phase 3 Alzheimer’s study last week. 2 end stage liver disease phase 3 studies next year. He hinted to a non-dilutive financing that this equity raise augments. He wasn’t happy with Think Equity about this deal. He said he was angry. He knows how to finance his companies. New highs not too far away?
TheWord321, published August 16, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!